LCLCX
Price
$55.63
Change
+$0.58 (+1.05%)
Updated
Aug 7 closing price
Net Assets
3.29B
VMGMX
Price
$131.82
Change
+$1.75 (+1.35%)
Updated
Aug 7 closing price
Net Assets
33.5B
Interact to see
Advertisement

LCLCX vs VMGMX

LCLCX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
LCLCX vs. VMGMX commentary
Aug 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCLCX is a Buy and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.5B vs. LCLCX (3.29B). VMGMX pays higher dividends than LCLCX: VMGMX (0.61) vs LCLCX (0.00). LCLCX was incepted earlier than VMGMX: LCLCX (13 years) vs VMGMX (15 years). LCLCX (2.08) is less costly to investors than VMGMX (0.07). LCLCX is a more actively managed with annual turnover of: 29.00 vs. VMGMX (17.00). LCLCX has a lower initial minimum investment than VMGMX: LCLCX (1000) vs VMGMX (3000). LCLCX annual gain was more profitable for investors over the last year : 9.77 vs. VMGMX (6.53). VMGMX return over 5 years is better than : 26.54 vs. LCLCX (5.92).
LCLCXVMGMXLCLCX / VMGMX
Total Expense Ratio2.080.072,971%
Annual Report Gross Expense Ratio2.080.072,971%
Fund Existence13 years15 years-
Gain YTD6.6539.76268%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets3.29B33.5B10%
Annual Yield % from dividends0.000.61-
Returns for 1 year9.776.53150%
Returns for 3 years44.7649.8890%
Returns for 5 years5.9226.5422%
Returns for 10 years279.21191.13146%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEPH4.210.62
+17.27%
Nephros
IPSC2.000.10
+5.26%
Century Therapeutics
HLI129.001.42
+1.11%
Houlihan Lokey
DYNCU10.86N/A
N/A
Dynamix Corporation
TCBK57.27-0.27
-0.47%
TriCo Bancshares